Literature DB >> 2409115

Intestinal metaplasia in endoscopic biopsy specimens of gastric mucosa.

G A Rothery, D W Day.   

Abstract

A total of 1412 consecutive cases of endoscopic gastric biopsy, carried out over a four year period, were reviewed and specimens were examined histochemically to determine the prevalence of intestinal metaplasia and its variants. Three types were characterised: complete intestinal metaplasia and two classes of incomplete intestinal metaplasia (type IIa and type IIb) depending on the absence or presence, respectively, of sulphomucins within mucin secreting columnar cells. Type IIb intestinal metaplasia was significantly more common in patients with gastric carcinoma (p less than 0.001) and in those with dysplasia (p less than 0.001) than in patients with benign gastric pathology. No such association was found with either type I or type IIa intestinal metaplasia. In addition to those present in the columnar cells of type IIb intestinal metaplasia, sulphomucins were also commonly found in goblet cells of all three types of metaplasia. The presence of sulphomucins in goblet cells, however, was not significantly associated with gastric carcinoma or dysplasia. The significance of the different types of intestinal metaplasia in relation to the pathological findings is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409115      PMCID: PMC499258          DOI: 10.1136/jcp.38.6.613

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  27 in total

1.  DIAMINE METHODS FOR DIFFERENTIALING MUCOSUBSTANCES HISTOCHEMICALLY.

Authors:  S S SPICER
Journal:  J Histochem Cytochem       Date:  1965-03       Impact factor: 2.479

2.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

3.  Intestinal metaplasia with colonic-type sulphomucins in the gastric mucosa; its association with gastric carcinoma.

Authors:  P Sipponen; K Seppälä; K Varis; L Hjelt; T Ihamäki; M Kekki; M Siurala
Journal:  Acta Pathol Microbiol Scand A       Date:  1980-07

4.  Comparative electron microscopic features of normal intermediate and metaplastic pyloric epithelium.

Authors:  M Stockton; I McColl
Journal:  Histopathology       Date:  1983-11       Impact factor: 5.087

5.  Types of mucosal metaplasia in relation to the histogenesis of gastric carcinoma.

Authors:  D N Lei; J Y Yu
Journal:  Arch Pathol Lab Med       Date:  1984-03       Impact factor: 5.534

6.  Histochemical characterization of different types of intestinal metaplasia in gastric mucosa.

Authors:  D I Segura; C Montero
Journal:  Cancer       Date:  1983-08-01       Impact factor: 6.860

7.  Gastric carcinoma and intestinal metaplasia. Significance of types of intestinal metaplasia upon development of gastric carcinoma.

Authors:  F Iida; J Kusama
Journal:  Cancer       Date:  1982-12-15       Impact factor: 6.860

8.  Intestinal metaplasia of the gastric mucosa.

Authors:  B C MORSON
Journal:  Br J Cancer       Date:  1955-09       Impact factor: 7.640

9.  Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa.

Authors:  B C MORSON
Journal:  Br J Cancer       Date:  1955-09       Impact factor: 7.640

10.  Age-related trends of gastritis and intestinal metaplasia in gastric carcinoma patients and in controls representing the population at large.

Authors:  P Sipponen; M Kekki; M Siurala
Journal:  Br J Cancer       Date:  1984-04       Impact factor: 7.640

View more
  9 in total

Review 1.  Gastric cancer.

Authors:  P McCulloch
Journal:  Postgrad Med J       Date:  1996-08       Impact factor: 2.401

Review 2.  Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence.

Authors:  Carlos A González; José M Sanz-Anquela; Javier P Gisbert; Pelayo Correa
Journal:  Int J Cancer       Date:  2013-02-05       Impact factor: 7.396

3.  Variants of intestinal metaplasia in the evolution of chronic atrophic gastritis and gastric ulcer. A follow up study.

Authors:  S Silva; M I Filipe; A Pinho
Journal:  Gut       Date:  1990-10       Impact factor: 23.059

4.  Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma.

Authors:  Yao Zheng; Lin Wang; Jian-Ping Zhang; Jing-Yan Yang; Zhu-Mei Zhao; Xiao-Ying Zhang
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

5.  Expression and significance of p53 and mdm2 in atypical intestinal metaplasia and gastric carcinoma.

Authors:  Lin Wang; Xiao-Ying Zhang; Ling Xu; Wen-Jun Liu; Juan Zhang; Jian-Ping Zhang
Journal:  Oncol Lett       Date:  2011-04-14       Impact factor: 2.967

6.  Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up.

Authors:  T Rokkas; M I Filipe; G E Sladen
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

Review 7.  Pathophysiological effects of long-term acid suppression in man.

Authors:  R F McCloy; R Arnold; K D Bardhan; D Cattan; E Klinkenberg-Knol; P N Maton; R H Riddell; P Sipponen; A Walan
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

8.  Limited value of type III intestinal metaplasia in predicting risk of gastric carcinoma.

Authors:  K C Ramesar; D S Sanders; D Hopwood
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

9.  Mucin histochemistry of stomach in metaplasia and adenocarcinoma: An observation.

Authors:  Prakas Kumar Mandal; Sudipta Chakrabarti; Amit Ray; Bitan Chattopadhyay; Shikha Das
Journal:  Indian J Med Paediatr Oncol       Date:  2013-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.